Nicholas Mai

9PUBLICATIONS
43CO-AUTHORS
Molecular targetsClinical midwiferyCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 02, 2025
Precision Oncology: 2025 in Review.

Nicholas Mai, Nicole Fernandez, Alexander Drilon

|Nov 10, 2025
Trastuzumab Deruxtecan Resistance via Loss of HER2 Expression and Binding.

Wanyi Chen, Avantika Gupta, Nicholas Mai

|Jul 21, 2025
eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer.

Jacob A Boyer, Ezra Y Rosen, Malvika Sharma

|May 29, 2025
Sequential Antibody-Drug Conjugate Therapy in Patients With Metastatic Breast Cancer Treated With Sacituzumab Govitecan and Trastuzumab Deruxtecan.

|Oct 18, 2024
Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancer.

Nicholas Mai, Carlos H Dos Anjos, Pedram Razavi

|Jul 28, 2024
Pathologic complete response to KEYNOTE522 and HER2-directed therapy for synchronous TNBC and HER2+ breast cancer.

Nicholas Mai, Jie-Fu Chen, Satshil Rana

Pageof 2

Frequent Collaborators

6 joint publications

Sarat Chandarlapaty

4 joint publications

Pedram Razavi

3 joint publications

Larry Norton

3 joint publications

Mark Robson